Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia
NCT07247292 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-02-19
Summary
This is a multi-centre, retrospective-prospective, single-arm, non-interventional (observational) cohort study with secondary data collection within real-world settings of participants with AQP4-IgG positive NMOSD.
Conditions
- Rare Diseases
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-23
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Russia
Study Locations
More Related Trials
-
Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders
NCT03350633 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder
NCT06673394 ·Status: WITHDRAWN ·Phase: PHASE2
-
BLAZE-Limiting Approach in NMOSD
NCT06888622 ·Status: COMPLETED
-
Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders
NCT04064944 ·Status: UNKNOWN ·Phase: PHASE2
-
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
NCT06497374 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
NCT07247279 ·Status: RECRUITING
-
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
NCT01892345 ·Status: TERMINATED ·Phase: PHASE3
-
Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD
NCT07132398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
NCT06044350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
NCT04201262 ·Status: COMPLETED ·Phase: PHASE3
-
An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
NCT04388072 ·Status: COMPLETED
-
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
NCT05145361 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
NCT00904826 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
NCT06118398 ·Status: NOT_YET_RECRUITING
-
Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT06180278 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06742190 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
NCT06413654 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
NCT05346354 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
NCT02028884 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Transplant To End NMO Spectrum Disorder
NCT03829566 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
NCT07010302 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
NCT05891379 ·Status: RECRUITING
-
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539 ·Status: COMPLETED
-
Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder
NCT07032337 ·Status: COMPLETED